LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$29.79
−0.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 54.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.93x
- PEG TTM
- —
- Price / book
- 0.53x
- Price / sales
- 1.76x
- Price / cash flow
- -9.02x
Enterprise value
- Enterprise value
- -$553.4M
- EV / sales
- -0.50x
- EV / EBITDA
- -0.92x
- EV / EBIT
- -0.81x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026